Crimson Publishers Publish With Us Reprints e-Books Video articles


Cohesive Journal of Microbiology & Infectious Disease

Assessment of Vaccination Coverage Required for Covid-19 Incidence Control

  • Open or CloseAndrey Gerasimov*

    Sechenov First Moscow State Medical University, Russia

    *Corresponding author:Andrey Gerasimov, Sechenov First Moscow State Medical University, Russia

Submission: October 27, 2020; Published: November 18, 2020

DOI: 10.31031/CJMI.2020.04.000590

ISSN: 2578-0190
Volume4 Issue3


For the vast majority of countries, effective control over COVID-19 incidence without mass vaccination is not possible. More than 100 research centers are successfully developing and testing the vaccine; mass vaccination can be expected from early 2021. The article describes how to evaluate the activity of the transmission mechanism and the necessary level of collective immune status, created by vaccination, taking into account the “seasonal factor” and collective immunity received from diseases of coronavirus infection. In particular, for Moscow the minimum proportion of the population that needs to become immune is currently 48.7%, if inoculated without serological control, and 36.5% if inoculation receive those who have no immunity.

Keywords: COVID-19; Effect of vaccination against COVID-19; Mathematical model.

Get access to the full text of this article

About Crimson

We at Crimson Publishing are a group of people with a combined passion for science and research, who wants to bring to the world a unified platform where all scientific know-how is available read more...

Leave a comment

Contact Info

  • Crimson Publishers, LLC
  • 555 Madison Avenue, 5th floor
  •     New York, NY 10022, USA
  • +1 (929) 600-8049
  • +1 (929) 447-1137